Saturday 17 October 2026 Export DTIL’s income statement to Excel — free account

Precision BioSciences, Inc.

Precision BioSciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.3 million, down 50.1% from fiscal 2024. In the quarter to June 2026, revenue grew 37,272.4%, EPS grew 40.9%, free cash flow grew 33.7% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

5.77 0.40 −6.48%

Follow DTIL

Alert me

Market cap: $170.3M
P/E: 0.0×
Fwd P/E: −2.6×
Dividend yield: —
F-score: 1/9
Altman Z: −4.31
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	—	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	—	3.01	1.56	93.46
P/FCF ratio Full definition →	—	0.00	0.00	0.00
P/Operating CF Full definition →	—	(11.35)	(4.74)	(4.27)
P/B ratio Full definition →	—	1.78	0.58	3.92
Price to Tangible BV Full definition →	—	1.81	0.59	4.17
EV/Sales Full definition →	—	1.26	(1.16)	61.23
EV/EBITDA Full definition →	—	0.00	0.80	0.00
EV/Operating CF Full definition →	—	(0.97)	0.60	(0.58)
EV/FCF Full definition →	—	(0.96)	0.60	(0.58)
Quick Ratio Full definition →	12.26	13.56	12.97	2.99
Current Ratio Full definition →	12.82	14.02	13.32	3.45
Net Debt/EBITDA Full definition →	3.51	9.34	(7.07)	1.11
Debt/Assets Full definition →	17.81%	15.58%	14.51%	23.93%
Debt/Equity Full definition →	0.50	0.29	0.24	1.35
Asset Turnover Full definition →	0.00	0.34	0.24	0.01
Operating CF/Net income Full definition →	0.41	0.65	(0.56)	0.70
Capex/Depreciation Full definition →	0.00	(0.18)	(0.48)	0.04
Interest Coverage Full definition →	(63.87)	(29.18)	35.94	(57.09)
Research and Development Expense of Revenue Full definition →	0.00%	120.96%	42.29%	102,707.69%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	62.77%	21.14%	56,369.23%
Intangible Assets out of Total Assets Full definition →	0.01	0.01	0.01	0.01
Share Based Compensation of Revenue Full definition →	0.00%	14.29%	5.97%	18,353.85%
Graham Net Nets Full definition →	—	0.30	1.06	(0.39)
Graham Number Full definition →	—	0.00	0.00	0.00
Earnings Yield Full definition →	—	(66.55%)	(123.08%)	(152.17%)
Free Cash Flow Yield Full definition →	—	(43.67%)	(124.59%)	(112.95%)
Revenue per Share Full definition →	0.00	0.44	2.67	0.00
Operating CF per Share Full definition →	(0.52)	(0.48)	(0.88)	(1.29)
Capex per Share Full definition →	0.00	0.00	(0.03)	0.00
Free Cash Flow per Share Full definition →	(0.52)	(0.49)	(0.90)	(1.29)
Cash per Share Full definition →	3.39	4.11	9.01	3.80
Shareholders Equity per Share Full definition →	1.75	3.09	7.19	1.41
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.75	3.09	7.19	1.41
Free Cash Flow Full definition →	(13.44)	(12.05)	(11.57)	(15.25)
Working Capital Full definition →	84.41	100.94	109.83	36.71
Capital Expenditures Full definition →	0.00	(0.11)	(0.32)	0.02
Net Current Asset Value Full definition →	10.92	40.90	56.57	(25.17)
EV/EBIT Full definition →	—	0.00	0.76	0.00
Capex to Sales Full definition →	0.00	0.01	0.01	(1.31)
Price to Operating Income Full definition →	—	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	—	2.09	—	0.11
Average Payables Full definition →	0.97	0.93	0.80	1.15
Average Assets Full definition →	117.42	134.15	145.40	123.38
Average Common Equity Full definition →	39.67	62.72	74.32	40.75

Fold the line items

Columns are period end dates

Stockrow Weekly